Carotid cavernous fistula (CCF) treatment approaches: A systematic literature review and meta-analysis of transarterial and transvenous embolization for direct and indirect CCFs

Pavlos Texakalidis,Andreas Tzoumas,Dimitrios Xenos,Dennis J Rivet,John Reavey-Cantwell,Dennis J. Rivet
DOI: https://doi.org/10.1016/j.clineuro.2021.106601
IF: 1.885
2021-05-01
Clinical Neurology and Neurosurgery
Abstract:Carotid Cavernous Fistulas (CCF) can be direct and indirect.Most common therapy for CCF consists of transarterial or transvenous embolization.Both procedures are associated with very high success and low complication rates.Surgical treatment can be attempted in refractory cases.Carotid Cavernous Fistulas (CCFs) are the result of an abnormal communication between the carotid artery and its branches and the venous system of the cavernous sinus. The mainstay of therapy for CCFs consists of transarterial or transvenous embolization, while other treatment options such as open surgery or radiosurgery are still utilized as second-line or adjuvant therapeutic options.Our aim was to systematically review and summarize available data regarding short- and long-term outcomes of all available treatment modalities for CCFs.This systematic review was conducted according to the PRISMA guidelines. A random effects model meta-analysis was conducted.Fifty-seven studies comprising 1,575 patients were included in this systematic review. Transarterial embolization for direct and indirect CCFs offered a complete obliteration rate of 93.93% (N=589/627) and 81.51% (N=119/146), respectively. Transvenous embolization for direct and indirect lesions achieved obliteration in 91.67% (N=33/36) and 86.03% (N=425/494) of patients, respectively. Comparison between transarterial and transvenous embolization did not reveal statistically significant differences in terms of fistula obliteration for direct (OR: 1.42; 95% CI: 0.23-8.90; I<sup>2</sup> 0.0%) and indirect CCFs (OR: 0.62; 95% CI: 0.31-1.23; I<sup>2</sup> 0.0%).Endovascular embolization techniques are the preferred treatment modality for the management of CCFs. No differences were identified between transarterial and transvenous embolization by synthesizing studies with available data. Future prospective cohorts are warranted to compare the different materials and techniques implemented especially within the rapidly expanding realm of endovascular approaches.
surgery,clinical neurology
What problem does this paper attempt to address?